GE

Genflow Biosciences PLCLSE Genflow Biosciences Stock Report

Last reporting period 30 Jun, 2023

Updated 29 Oct, 2024

Last price

Market cap $B

0.01

Micro

Exchange

XLON - London Stock Exchange

View Section: Price ratios

Genflow Biosciences Statements

GE

Data from Genflow Biosciences`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

GBP - British pound

Last reporting period:

30 Jun, 2023

Next reporting period:

27 Dec, 2023

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

Genflow Biosciences Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

GBP (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-06-30
%

100

0

0

0.415

0

0.4

0

0.621

-2.7 %

0

-0.621

2.7 %

0

0

0

0

-0.622

-10.7 %

0

0

-0.622

-10.7 %

0

-0.002

292.51

2022-12-31
%

100

0

0

0

1.126

0

0.639

-17.4 %

0

-0.639

17.4 %

0

0

0

0.077

0

-0.562

27.4 %

0

0

-0.562

27.4 %

0

-0.002

295.16

2022-06-30
%

100

0

0

0

0.696

0

0.773

6.8 %

0

-0.773

-6.8 %

0

0

0

0

-0.774

-7.1 %

0

0

-0.774

-7.1 %

0

-0.003

289.86

2021-12-31
%

100

0

0

0

0.674

0

0.724

174.3 %

0

-0.724

-174.3 %

0

0.001

0

0

-0.723

-172.1 %

0

0

-0.723

-172.1 %

0

-0.018

40.833

2021-06-30
%

100

0

0

0

0.264

0

0.264

0

-0.264

0

-0.002

0

0

-0.266

0

0

-0.266

0

-0.001

292.51

View Section: Balance Sheet